GLCCI1 and asthma: The results of this study suggested that patients carrying the G allele may exhibit reduced ICS therapeutic efficacy after ICS administration and that the analysis of GLCCI1 (rs37973 G > A) in asthma patients will help provide a scientific guidance for the clinical use of ICS.